Gilead Sciences

Biotechnology
GILD
$ 63 (1.4)%
Share price
$ 79 bn
Market Cap
$ 99 bn
Enterprise Value

Carbon footprint

0.9 Ton
GHG emissions per $ 1 mln investment
0.02x the weighted average for S&P 500
FY2021
How is this calculated?
+11%
YOY change in GHG emissions
Stronger than the +4.9% weighted average for S&P 500
FY2021 vs. previous year

Primary Climate Goal

-5.2%
Proj. YOY change in GHG emissions (Scope 1 + 2)
Weaker than the -6.6% weighted average for S&P 500
FY2022
How is this calculated?

Gilead Sciences aims to reduce Scope 1 + 2 by 46% by 2030 from a base year 2019


1.5°C
Gilead Sciences's actual and proj. GHG emissions (Scope 1 + 2) (Kt of CO2e)

Secondary Climate Goal

Gilead Sciences aims to reduce Scope 3 by 15% by 2030 from a base year 2019


1.5°C

GHG emissions and Carbon intensity

Gilead Sciences's GHG emissions (market-based) (Kt of CO2e)
Gilead Sciences's Carbon intensity (Tons per 1 USDm)

Gilead Sciences's carbon footprint

Gilead Sciences reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2021 at 89 Kt (+8.5/+11% y-o-y). Carbon intensity also remained unchnaged at 3.2 t.

Gilead Sciences's Scope 3 emissions took off to 38 Kt (+5.1/+16% y-o-y). This is a higher growth rate than over the period since 4Q'16 (+6.1% CAGR).

The company is committed to reducing Scope 1 + 2 by 46% by 2030 from a base year 2019, which translates into the estimated reduction of -4.6 Kt per annum over the period of FY2022 - FY2030. This science-based target is aligned with Paris Agreement to limit global warming to 1.5°C above pre-industrial levels.

Company environmental metrics

Show more...